Review finds limited evidence on non-medical care in canine Cushing’s
Bottom line
A new systematic review and network meta-analysis in Veterinary Sciences examined non-medical treatment options for canine Cushing’s syndrome and found the evidence base is still thin. The review included five studies covering 248 dogs and focused on adrenalectomy techniques for adrenal-dependent disease, plus radiation therapy for pituitary-dependent disease. The authors concluded that non-medical interventions may offer benefit in selected cases, but the available studies were small and heterogeneous, limiting confidence in direct comparisons across approaches. (mdpi.com)
Why it matters: For veterinary professionals, the paper is less a practice-changing result than a reality check on the literature. Current guidance already positions adrenalectomy as the treatment of choice for functional adrenal tumors and reserves pituitary radiation or surgery for selected dogs, especially those with macroadenomas or neurologic signs. The review reinforces that referral decisions still depend heavily on case selection, imaging, surgical expertise, and pet parent goals, because high-quality comparative outcome data remain limited. Recent surgical literature also suggests laparoscopic adrenalectomy can shorten hospitalization in well-selected dogs, while broader guidance stresses CT-based staging before adrenalectomy and ongoing medical support after pituitary radiation because endocrine control may take months. (aaha.org)
What to watch: The next step is whether prospective, standardized studies can clarify which dogs benefit most from laparoscopic versus open adrenalectomy, and how radiation outcomes compare with long-term medical management. (mdpi.com)
Key facts
- Study type
- Systematic review and network meta-analysis
- Journal
- Veterinary Sciences
- Publication date
- August 2026
- Dogs included
- 248
- Studies included
- 5
- Main focus
- Non-medical treatment options for canine Cushing’s syndrome
- Interventions assessed
- Laparoscopic and open adrenalectomy, and radiation therapy
- Main finding
- Evidence was thin, small, and heterogeneous, limiting direct comparisons
A newly published systematic review and network meta-analysis is putting a spotlight on an old problem in canine Cushing’s syndrome: veterinarians have non-medical options, but not much high-quality comparative evidence to guide when to use them. Published in Veterinary Sciences in August 2026, the review evaluated survival, perioperative outcomes, and clinical outcomes tied to non-medical interventions in dogs with Cushing’s syndrome. (mdpi.com)
That question matters because canine Cushing’s syndrome is not one disease with one pathway. Most cases are pituitary-dependent, while adrenal-dependent disease accounts for a smaller share, and treatment choices differ accordingly. AAHA guidance notes that dogs with adrenal tumors may move toward adrenalectomy, while dogs with pituitary-dependent disease may be managed medically, or considered for radiation therapy or hypophysectomy in selected cases. (aaha.org)
The review itself found only five eligible studies, totaling 248 dogs, underscoring how limited the evidence base remains. According to the paper summary, three studies assessed laparoscopic and open adrenalectomy in dogs with adrenal-dependent hypercortisolism, while other included data addressed radiation therapy for pituitary-dependent disease. The authors’ central message was cautious: non-medical treatment can be clinically important, but the published evidence is too sparse and inconsistent to support strong comparative conclusions. (mdpi.com)
Outside the review, the broader literature helps explain why this question is hard to settle. A 2023 retrospective study in Frontiers in Veterinary Science found adrenalectomy remains the treatment of choice for functional adrenal tumors when there is no detected metastasis, and reported no clear long-term survival difference between laparoscopic and open approaches in prior canine data. In that same paper, the authors noted shorter hospitalization after laparoscopic adrenalectomy in their cohort, while also emphasizing the importance of careful staging and workup because cortisol-secreting tumors can raise perioperative risk, including thromboembolic and hemodynamic complications. (frontiersin.org)
Guidelines and reference texts also frame radiation therapy as a more selective tool than a routine first-line option. Merck states that radiotherapy is indicated when a dog has a large pituitary tumor and neurologic signs, and notes that most dogs still need ancillary trilostane or mitotane for months after treatment because endocrine control is not immediate. AAHA similarly recommends head CT in pituitary-dependent cases when a clinician or pet parent would pursue radiation therapy or hypophysectomy, and abdominal CT before adrenalectomy in adrenal-dependent disease. (merckvetmanual.com)
Why it matters: For practicing veterinarians, this review is useful not because it settles the debate, but because it defines the limits of what the literature can currently support. When discussing options with pet parents, clinicians still need to anchor recommendations in tumor type, imaging findings, comorbidities, referral access, and local expertise. In adrenal-dependent disease, surgery remains an established pathway, but approach selection may hinge more on anatomy and surgeon experience than on definitive comparative survival data. In pituitary-dependent disease, radiation may be most relevant for dogs with macroadenomas or neurologic progression, rather than as a broad substitute for medical management. (merckvetmanual.com)
The paper also highlights a research gap with practical consequences. Veterinary teams are often asked not just whether a treatment works, but which treatment works best for a specific dog, with what complication profile, and over what timeline. Right now, the answer is still shaped by retrospective datasets, small case numbers, and inconsistent outcome reporting. That makes referral conversations, perioperative planning, and expectation-setting especially important. (mdpi.com)
What to watch: The field now needs prospective studies with standardized definitions for survival, recurrence, perioperative complications, and quality-of-life outcomes, especially for laparoscopic versus open adrenalectomy and for radiation therapy in pituitary-dependent disease. Until then, this review is likely to serve more as a map of the evidence gaps than a trigger for immediate protocol changes. (mdpi.com)